Market News

Insight Into RKDA Stock: Arcadia Biosciences Surpasses EPS Expectations, Falls Short on Revenue in Q4 2023

by Ron Finklestien

Published On: March 28, 2024 10:34 pm

RKDA stock - RKDA Stock Earnings: Arcadia Biosciences Beats EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

Arcadia Biosciences (NASDAQ:RKDA) has recently unveiled the results for the final quarter of 2023.

Arcadia Biosciences achieved earnings per share of -$2.10, surpassing the analyst projection of -$2.58.
The company recorded revenue amounting to $1.17 million.
This figure fell short by 33.14% compared to the analyst’s revenue expectation of $1.75 million.

InvestorPlace Earnings utilizes TradeSmith data to automate comprehensive coverage of quarterly earnings statements. This approach distills critical insights such as earnings per share and revenue, while also evaluating a company’s performance against analyst forecasts. These articles are generated autonomously, enabling us to promptly deliver the latest financial results to our audience. For any concerns or corrections, please contact us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/rkda-stock-earnings-arcadia-biosciences-for-q4-of-2023/.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.